MCID: RRT020
MIFTS: 41

Rare Tumor

Categories: Cancer diseases, Eye diseases, Rare diseases

Aliases & Classifications for Rare Tumor

MalaCards integrated aliases for Rare Tumor:

Name: Rare Tumor 58
Rare Neoplasm 58

Classifications:



External Ids:

UMLS via Orphanet 72 C0375111
Orphanet 58 ORPHA98057

Summaries for Rare Tumor

MalaCards based summary : Rare Tumor, also known as rare neoplasm, is related to desmoplastic small round cell tumor and dermatofibrosarcoma protuberans. An important gene associated with Rare Tumor is EWSR1 (EWS RNA Binding Protein 1), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Cytoskeletal Signaling. The drugs leucovorin and Methylcobalamin have been mentioned in the context of this disorder. Affiliated tissues include breast, pancreas and thyroid, and related phenotypes are homeostasis/metabolism and mortality/aging

Related Diseases for Rare Tumor

Diseases in the Rare Tumor family:

Rare Eye Tumor

Diseases related to Rare Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 679)
# Related Disease Score Top Affiliating Genes
1 desmoplastic small round cell tumor 32.3 EWSR1 DES
2 dermatofibrosarcoma protuberans 31.7 KIT DES ACTC1
3 spindle cell sarcoma 30.4 NF2 DES ACTC1
4 fibromatosis 30.2 DES ACTC1
5 leiomyosarcoma 30.2 KIT DES ACTC1
6 lipomatosis, multiple 30.2 KIT EWSR1 DES
7 fibrous histiocytoma 30.1 EWSR1 DES ACTC1
8 paraganglioma 30.1 SST RET KIT
9 leiomyoma 30.1 KIT DES ACTC1
10 sarcoma, synovial 30.0 KIT EWSR1 DES
11 hemangioma 30.0 RET KIT ACTC1
12 syringocystadenoma papilliferum 30.0 DES ACTC1
13 spindle cell lipoma 29.9 DES ACTC1
14 rhabdoid tumor predisposition syndrome 1 29.9 DES ACTC1
15 histiocytoma 29.9 KIT EWSR1 ACTC1
16 carcinosarcoma 29.9 KIT DES ACTC1
17 teratoma 29.9 SST KIT ACTC1
18 alveolar soft part sarcoma 29.9 RET DES ACTC1
19 biphasic synovial sarcoma 29.7 EWSR1 DES
20 chondroma 29.7 KIT ACTC1
21 congenital fibrosarcoma 29.7 EWSR1 DES ACTC1
22 angiolipoma 29.7 DES ACTC1
23 glomangioma 29.7 DES ACTC1
24 parachordoma 29.7 DES ACTC1
25 rhabdomyosarcoma 29.7 KIT EWSR1 DES ACTC1
26 desmoid tumor 29.7 KIT DES ACTC1
27 angiomyolipoma 29.7 KIT DES ACTC1
28 neurofibromatosis, type iv, of riccardi 29.6 RET NF2 KIT
29 ossifying fibromyxoid tumor 29.6 DES ACTC1
30 cellular myxoid liposarcoma 29.6 KIT EWSR1
31 hemangiopericytoma, malignant 29.6 KIT DES ACTC1
32 neurilemmoma 29.6 NF2 KIT DES ACTC1
33 follicular dendritic cell sarcoma 29.6 KIT FCER2 CR2
34 chondromyxoid fibroma 29.6 DES ACTC1
35 bladder leiomyoma 29.6 KIT EWSR1
36 neurofibroma 29.5 NF2 KIT ACTC1
37 myoepithelial carcinoma 29.5 EWSR1 ACTC1
38 ewing sarcoma 29.5 RET KIT EWSR1 DES
39 perivascular epithelioid cell tumor 29.4 KIT DES ACTC1
40 adenosarcoma 29.4 KIT DES ACTC1
41 embryonal sarcoma 29.4 KIT DES
42 mesenchymoma 29.4 KIT DES
43 reticulum cell sarcoma 29.4 FCER2 DES CR2 ACTC1
44 sarcoma 29.2 RET NF2 KIT EWSR1 CR2 ACTC1
45 muscle cancer 29.2 KIT EWSR1 DES
46 constipation 29.2 SST RET KIT EWSR1
47 perineurioma 29.2 KIT ACTC1
48 malignant peripheral nerve sheath tumor 29.1 NF2 KIT ACTC1
49 pleomorphic liposarcoma 29.1 KIT EWSR1 DES ACTC1
50 smooth muscle tumor 29.1 KIT DES CR2 ACTC1

Graphical network of the top 20 diseases related to Rare Tumor:



Diseases related to Rare Tumor

Symptoms & Phenotypes for Rare Tumor

MGI Mouse Phenotypes related to Rare Tumor:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.85 ACTC1 CR2 DES FCER2 KIT LATS2
2 mortality/aging MP:0010768 9.7 ACTC1 CR2 DES FCER2 FSCN1 KIT
3 muscle MP:0005369 9.1 ACTC1 DES KIT LATS2 MMP2 RET

Drugs & Therapeutics for Rare Tumor

Drugs for Rare Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 118)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 2, Phase 3 58-05-9 6006 143
2
Methylcobalamin Approved, Investigational Phase 2, Phase 3 13422-55-4
3
Hydroxocobalamin Approved Phase 2, Phase 3 13422-51-0 11953898 15589840
4
Bevacizumab Approved, Investigational Phase 2, Phase 3 216974-75-3
5
Pemetrexed Approved, Investigational Phase 2, Phase 3 150399-23-8, 137281-23-3 446556 60843
6
Folic acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-30-3 6037
7
Cyanocobalamin Approved, Nutraceutical Phase 2, Phase 3 68-19-9 44176380
8
Cobalamin Experimental Phase 2, Phase 3 13408-78-1 6857388
9 Folic Acid Antagonists Phase 2, Phase 3
10 Vitamin B9 Phase 2, Phase 3
11 Vitamin B Complex Phase 2, Phase 3
12 Folate Phase 2, Phase 3
13 Vitamins Phase 2, Phase 3
14 Vitamin B 12 Phase 2, Phase 3
15 Vitamin B12 Phase 2, Phase 3
16
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
17
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
18
Etoposide Approved Phase 2 33419-42-0 36462
19
Mitotane Approved Phase 2 53-19-0 4211
20
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
21
Palbociclib Approved, Investigational Phase 2 571190-30-2 11431660 5005498 5330286
22
Olaparib Approved Phase 2 763113-22-0 23725625
23
Dabrafenib Approved, Investigational Phase 2 1195765-45-7 44462760 44516822
24
afatinib Approved Phase 2 850140-72-6, 439081-18-2 10184653
25
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
26
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
27
Vemurafenib Approved Phase 2 918504-65-1 23252090 42611257
28
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
29
Trastuzumab Approved, Investigational Phase 2 180288-69-1 9903
30
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
31
Durvalumab Approved, Investigational Phase 2 1428935-60-7
32
Ifosfamide Approved Phase 2 3778-73-2 3690
33
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
34
Tamoxifen Approved Phase 2 10540-29-1 2733526
35
Progesterone Approved, Vet_approved Phase 2 57-83-0 5994
36
rituximab Approved Phase 2 174722-31-7 10201696
37
Rucaparib Approved, Investigational Phase 2 283173-50-2 9931954
38
Oxaliplatin Approved, Investigational Phase 2 61825-94-3 5310940 9887054 6857599 43805
39
Gemcitabine Approved Phase 2 95058-81-4 60750
40
Dopamine Approved Phase 2 51-61-6, 62-31-7 681
41
Salmon Calcitonin Approved, Investigational Phase 2 47931-85-1 16129616
42
Levodopa Approved Phase 2 59-92-7 6047
43
Imiquimod Approved, Investigational Phase 1, Phase 2 99011-02-6 57469
44
Tremelimumab Investigational Phase 2 745013-59-6
45
Calcitonin gene-related peptide Investigational Phase 2 83652-28-2
46 Antimitotic Agents Phase 2
47
Liposomal doxorubicin Phase 2 31703
48 Etoposide phosphate Phase 2
49 Topoisomerase Inhibitors Phase 2
50 polysaccharide-K Phase 2

Interventional clinical trials:

(show all 43)
# Name Status NCT ID Phase Drugs
1 A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM) Completed NCT00651456 Phase 2, Phase 3 Standard Chemotherapy (Pemetrexed and Cisplatin);Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab
2 Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma Completed NCT01833832 Phase 2 Cisplatin;sodium thiosulfate
3 A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection Completed NCT00071058 Phase 2 XR9576 (Tariquidar)
4 Efficacy and Safety of Targeted Precision Therapy in Refractory Tumor With Druggable Molecular Event Recruiting NCT03239015 Phase 2 Gefitinib;Erlotinib;Afatinib;Trastuzumab;Oxazolidine;Olaparib;Everolimus;Cabozantinib;Vemurafenib;Dabrafenib;Palbociclib
5 Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma Recruiting NCT03127774 Phase 2 Cisplatin;Sodium thiosulfate
6 A Phase II Study of Durvalumab (MEDI4736) (Anti-PD-L1 Antibody) in Combination With Tremelimumab (Anti-CTLA-4 Antibody) in Subjects With Advanced Rare Solid Tumors Recruiting NCT02938793 Phase 2 Durvalumab;Tremelimumab
7 Prospective Phase II Study Evaluating a Multimodal Care of Inguinal Node Metastasis in Squamous Cell Carcinoma of the Penis by Bilateral Lymphadenectomy and Chemotherapy TIP Recruiting NCT02817958 Phase 2 Chemotherapy TIP
8 Phase II Study of Hormone Therapy With Tamoxifen in Patients With Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression Recruiting NCT03870399 Phase 2 Tamoxifen
9 Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma. The International Extranodal Lymphoma Study Group (IELSG) 36 Phase II Prospective Study Active, not recruiting NCT02853370 Phase 2 Bendamustine and Rituximab
10 A Phase 2 Multicenter, Open-label Study of Rucaparib as Treatment for Solid Tumors Associated With Deleterious Mutations in Homologous Recombination Repair Genes Not yet recruiting NCT04171700 Phase 2 Rucaparib
11 A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study Suspended NCT01627795 Phase 1, Phase 2 Oshadi D and Oshadi R
12 Open Labeled Phase II Study Evaluating Efficacy and Safety of Chemotherapy With Gemcitabine - Oxaliplatin Combination for Advanced Refractory Thyroid Cancer Patients Terminated NCT02472080 Phase 2 gemcitabine -oxaliplatine combination
13 Efficacy and Tolerance of RADIOEMBOLIZATION for Patients With Unresectable Intrahepatic Cholangiocarcinoma With Tumor Progression After First-line Therapy Terminated NCT01383746 Phase 1, Phase 2
14 Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer. Terminated NCT00647140 Phase 2
15 Phase I/II Study of Peptide Vaccination Associated With GM-CT-01, a Galactomannan Oligomer That Inhibits Galectin-3, in Patients With Advanced Metastatic Melanoma Terminated NCT01723813 Phase 1, Phase 2
16 Phase I/II Study of Peptide Vaccination Associated With Tumoral Immunomodulation With Proinflammatory Cytokines and Imiquimod in Patients With Advanced Metastatic Melanoma Terminated NCT01191034 Phase 1, Phase 2 Vaccine MAGE-3.A1 peptide, or the NA17.A2 peptide + IL-2, IFN-α and GMCSF, Imiquimod.
17 Phase I/II Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors Completed NCT00183833 Phase 1 capecitabine, imatinib mesylate
18 Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate in Patient With Rare Tumor (Phase I Study) Completed NCT01046487 Phase 1 Imatinib mesylate, Cyclophosphamide (Dosing level 1 );Imatinib mesylate, Cyclophosphamide (Dosing level 2);Imatinib mesylate, Cyclophosphamide (Dosing level 3)
19 A Phase I Dose Escalation Study of Autologous Expanded Natural Killer (NK) Cells for Immunotherapy of Relapsed Refractory Neuroblastoma With Dinutuximab +/- Lenalidomide Recruiting NCT02573896 Phase 1 Ch14.18;Lenalidomide
20 A Phase I/II Trial of IL-13-PE in Patients With Treatment Refractory Malignancies With a Focus on Metastatic and Locally Advanced Adrenocortical Carcinoma Terminated NCT01832974 Phase 1 IL-13-PE
21 Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma Unknown status NCT01594203
22 Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Completed NCT02334930
23 Survival After Hepatectomy for Combined Hepatocellular Cholagiocarcinoma Completed NCT03178409
24 A Pilot Study of Combined Immunochemotherapy Followed by Reduced Dose RT for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Completed NCT00594815 Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine
25 Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study Completed NCT03774862
26 Procurement of Blood and Tissue From Patients With Primary and Metastatic Alveolar Soft Part Sarcoma and Blood From Healthy Controls for In Vitro and In Vivo Model Development Completed NCT00340353
27 Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma Completed NCT02015026
28 Sentinel Lymph Node Biopsy in Porocarcinoma: A Case Reports Completed NCT03647631
29 Retrospective Study of Cases of Small Cell Lung Cancer (SCLC) That Appeared During Treatment of Another Lung Carcinoma With or Without Oncogenic Activation (TransCPC) Completed NCT03419286
30 Natural History Study of Children and Adults With Chordoma Recruiting NCT03910465
31 International Pediatric Adrenocortical Tumor Registry Recruiting NCT00700414
32 Natural History and Biospecimen Acquisition Study for Children and Adults With Rare Solid Tumors Recruiting NCT03739827
33 Neuroblastoma Biology Studies Recruiting NCT00904241
34 International Pleuropulmonary Blastoma Registry for PPB, DICER1 and Associated Conditions Recruiting NCT03382158
35 Clinico-biological Study/Characterization of Rhabdomyosarcoma in AYA (Adolescents and Young Adults, 15-25-year-old Patients) Recruiting NCT03462888
36 DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study Recruiting NCT01247597
37 A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer Active, not recruiting NCT01802567
38 Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers Active, not recruiting NCT02162732
39 Family Study of Head and Neck Cancers in Taiwan Active, not recruiting NCT00342147
40 Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome Active, not recruiting NCT00565903
41 Measurement of Circulating Tumor Cells in Prostate Cancer Not yet recruiting NCT04101305
42 Rare Tumor Case Review Terminated NCT00229879
43 Topical Anesthesia to Decrease the Trigeminal-Cardiac Reflex During Intra-arterial Injection of Chemotherapy for Retinoblastoma in Children. Withdrawn NCT02955524 Early Phase 1 Tetracaine 0.5%;Lidocaine hydrochloride ophthalmic gel 3.5%

Search NIH Clinical Center for Rare Tumor

Genetic Tests for Rare Tumor

Anatomical Context for Rare Tumor

MalaCards organs/tissues related to Rare Tumor:

40
Breast, Pancreas, Thyroid, Liver, Lung, Bone, Kidney

Publications for Rare Tumor

Articles related to Rare Tumor:

(show top 50) (show all 9983)
# Title Authors PMID Year
1
Primary angiosarcoma of the breast: Case report of a rare vascular tumor. 61
31993096 2020
2
Dilemmas in Diagnosis and Management of Gastroenteropancreatic Mixed Neuroendocrine Non-neuroendocrine Neoplasms: First Single-Centre Report from India. 61
30784017 2020
3
Diagnosis of Mesothelioma. 61
32005436 2020
4
Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management. 61
31729020 2020
5
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival. 61
31757738 2020
6
Thyroid-Like Follicular Renal Cell Carcinoma Arising Within Benign Mixed Epithelial and Stromal Tumor. 61
31342803 2020
7
Angiomatosis of the Urinary Bladder: A New Anatomic Location for a Rare Tumor. 61
31454655 2020
8
Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience. 61
31738008 2020
9
Primary Angiosarcoma of the Kidney: Literature Review of a Rare Nosologic Entity. 61
32014903 2020
10
Precision medicine in Ewing sarcoma: a translational point of view. 61
32026343 2020
11
Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature. 61
31784095 2020
12
A Rare Pulmonary Artery Sarcoma Masquerading as Pulmonary Embolus. 61
31279785 2020
13
Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature. 61
32039736 2020
14
Surgical recurrence of solitary fibrous tumor of the pleura treated with microwave (MW) thermoablation: A case report. 61
31876364 2020
15
Cutaneous Syncytial Myoepithelioma: A Nondescript Skin Tumor With Serious Diagnostic Pitfalls. 61
31587595 2020
16
Primary Clear Cell Adenocarcinoma of the Head and Neck: A Population-Based Analysis. 61
32013719 2020
17
Intracholecystic Papillary-Tubular Neoplasms (ICPN) of the Gallbladder. 61
32039884 2020
18
Cervical Vagal Schwannoma Causing Asymptomatic Internal Carotid Artery Compression. 61
31629844 2020
19
Gastric schwannoma with high accumulation on fluorodeoxyglucose-positron emission tomography resected by non-exposed endoscopic wall-inversion surgery. 61
31270750 2020
20
The clinicoradiological features and surgical outcomes of primary intracranial fibrosarcoma: a single-institute experience with a systematic review. 61
32036505 2020
21
Merkel Cell Polyomavirus-Positive Panniculitic Merkel Cell Carcinoma: A Rare Neoplasm of Unknown Histogenesis. 61
30908296 2020
22
Epithelial myoepithelial carcinoma of the parotid gland: A rare tumor with oncocytic changes. 61
32031104 2020
23
Desmoplastic small round-cell tumour of the peritoneal cavity: case report and literature review. 61
31973562 2020
24
Conjunctival Melanoma: Current Treatments and Future Options. 61
31965542 2020
25
Signet-ring cell carcinoma of the ampulla of Vater: a case diagnosed via repeated biopsies. 61
31981088 2020
26
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors. 61
31969335 2020
27
Melanotic neuroectodermal tumor of infancy arising from the skull: report of an unusual case, review of the literature, and a diagnostic approach. 61
31897638 2020
28
Sarcomatoid chromophobe renal cell carcinoma revealed by acute pyelonephritis in a diabetic patient. 61
31681535 2020
29
A rare pericytic tumor of the kidney: The first case in Korea. 61
31855704 2020
30
Agenesis of the corpus callosum and hepatoblastoma. 61
31729153 2020
31
Wagner-Meissner neurilemmoma of the lip occurring in a patient with neurofibromatosis type 1: A case report. 61
31814976 2020
32
Melanotic neuroectodermal tumor of infancy to the skull: case-based review. 61
31953575 2020
33
Malignant peripheral nerve sheath tumor of the sciatic nerve presenting with leg pain in the setting of lumbar scoliosis and spinal stenosis. 61
31925758 2020
34
Very high rate of false positive biochemical results when screening for pheochromocytoma in a large, undifferentiated population with variable indications for testing. 61
31978379 2020
35
Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. 61
31992242 2020
36
A case report of temple squamoid eccrine ductal carcinoma: A diagnostic challenge beneath the tip of the iceberg. 61
31895497 2020
37
Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. 61
31701808 2020
38
Images - Oncocytic adrenocortical carcinoma: A rare tumor variant. 61
31658010 2020
39
Adrenocortical carcinoma in a young adult male with chronic urticaria: A case report and literature review. 61
31918158 2020
40
Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management. 61
31894378 2020
41
A Micellar Mitotane Formulation with High Drug-Loading and Solubility: Physico-Chemical Characterization and Cytotoxicity Studies in 2D and 3D In Vitro Tumor Models. 61
31596553 2020
42
Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck. 61
31950474 2020
43
Multiple recurrences of spindle cell oncocytoma: A case report and literature review. 61
31496509 2020
44
Difficult journeys in sarcoma care; socioeconomic disparity added to the multiple challenges of a rare tumor diagnosis. 61
31994423 2020
45
Primary cutaneous mucinous carcinoma of the scrotum: A rare tumor at a rare site - A case report and review of literature. 61
32015625 2020
46
[A rare pathology of the petrous part of the temporal bone: adenoma of the middle ear]. 61
31531685 2020
47
A case report of solitary neurofibroma of the Vas deferens. 61
31763167 2020
48
A case of submandibular desmoplastic small round cell tumor: Diagnostic and management approaches to an atypical presentation of a rare tumor. 61
31925924 2020
49
Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review. 61
31998498 2020
50
The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature. 61
31980959 2020

Variations for Rare Tumor

Expression for Rare Tumor

Search GEO for disease gene expression data for Rare Tumor.

Pathways for Rare Tumor

Pathways related to Rare Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.84 RET MMP2 KIT HLA-DRB1 FSCN1 FCER2
2 11.95 NF2 FSCN1 DES ACTC1
3 11.55 MMP2 FSCN1 FCER2
4 10.92 KIT HLA-DRB1 FCER2 CR2
5 10.86 KIT FCER2 CR2
6 10.83 NF2 LATS2

GO Terms for Rare Tumor

Cellular components related to Rare Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell-cell junction GO:0005911 9.33 KIT FSCN1 DES
2 lamellipodium GO:0030027 9.13 NF2 FSCN1 ACTC1
3 filopodium GO:0030175 8.8 NF2 FSCN1 ACTC1

Biological processes related to Rare Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 8.92 MMP2 KIT FSCN1 FCER2

Sources for Rare Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....